HELX vs. BNO
HELX (Franklin Genomic Advancements ETF) and BNO (United States Brent Oil Fund LP) are both exchange-traded funds - HELX is a Health & Biotech Equities fund actively managed by Franklin Templeton, while BNO is a Oil & Gas fund tracking the Crude Oil Brent ICE Near Term Futures. HELX is actively managed, while BNO is passively managed. Over the past 5 years, HELX returned -5.94%/yr vs 20.89%/yr for BNO. Their 0.03 correlation means their historical movements had little consistent relationship. HELX charges 0.50%/yr vs 1.00%/yr for BNO.
Performance
HELX vs. BNO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a 6.95% return, which is significantly lower than BNO's 77.90% return.
HELX
- 1D
- -2.30%
- 1M
- -5.21%
- 6M
- 6.44%
- YTD
- 6.95%
- 1Y
- 39.97%
- 3Y*
- 7.91%
- 5Y*
- -5.94%
- 10Y*
- —
- ALL TIME*
- 7.84%
BNO
- 1D
- 1.45%
- 1M
- 27.00%
- 6M
- 52.90%
- YTD
- 77.90%
- 1Y
- 62.83%
- 3Y*
- 20.31%
- 5Y*
- 20.89%
- 10Y*
- 15.06%
- ALL TIME*
- 4.31%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $107.13M | $97.34M | $147.52M | |
| $176.38K | $146.45K | $86.79K |
HELX vs. BNO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | 6.95% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 83.98% |
BNO United States Brent Oil Fund LP | 77.90% | -5.44% | 9.67% | -3.43% | 35.25% | 62.34% | -24.55% |
Correlation
The correlation between HELX and BNO is -0.31, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.31 |
Correlation (3Y) Balances recent behavior with more history. | -0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.03 |
Correlation (All Time) Calculated using the full available price history since Feb 27, 2020 | 0.03 |
The correlation between HELX and BNO shifts across timeframes, from -0.31 (1 year) to 0.03 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. BNO — Risk / Return Rank
HELX
BNO
HELX vs. BNO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and United States Brent Oil Fund LP (BNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HELX | BNO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.53 | ||
| Sortino ratioReturn per unit of downside risk | +0.67 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.24 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 2.25 | 1.70 | +0.55 |
| Martin ratioReturn relative to average drawdown | 5.64 | 5.15 | +0.49 |
Loading charts...
Drawdowns
HELX vs. BNO - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, smaller than the maximum BNO drawdown of -87.06%. Use the drawdown chart below to compare losses from any high point for HELX and BNO.
Loading charts...
Drawdown Indicators
| HELX | BNO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -87.06% | +28.31% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -34.46% | +16.45% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | -34.46% | +4.98% |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | -34.46% | -24.29% |
Max Drawdown (10Y)Largest decline over 10 years | — | -75.18% | — |
Current DrawdownCurrent decline from peak | -32.89% | -16.21% | -16.68% |
Average DrawdownAverage peak-to-trough decline | -34.28% | -39.99% | +5.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.16% | 11.86% | -4.70% |
Volatility
HELX vs. BNO - Volatility Comparison
The current volatility for Franklin Genomic Advancements ETF (HELX) is 6.37%, while United States Brent Oil Fund LP (BNO) has a volatility of 17.47%. This indicates that HELX experiences smaller price fluctuations and is considered to be less risky than BNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | BNO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.37% | 17.47% | -11.10% |
Volatility (6M)Calculated over the trailing 6-month period | 17.71% | 40.96% | -23.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.01% | 44.54% | -22.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.05% | 36.41% | -12.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.32% | 36.98% | -9.66% |
HELX vs. BNO - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is lower than BNO's 1.00% expense ratio.
Dividends
HELX vs. BNO - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.37%, while BNO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
BNO United States Brent Oil Fund LP | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HELX Franklin Genomic Advancements ETF | 0.37% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% |
Frequently Asked Questions
HELX and BNO have a correlation of -0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BNO has higher volatility (17.47%) compared to HELX (6.37%). In terms of maximum drawdown, HELX dropped -58.75% vs BNO's -87.06%.
On 5-year performance, BNO leads with 20.89% vs -5.94% for HELX. On fees, HELX is cheaper at 0.50% per year. On volatility, HELX has been the lower-risk option at 6.37%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BNO has performed better with a 20.89% return vs -5.94%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HELX is cheaper with a 0.50% expense ratio, compared with 1.00% for BNO.
HELX has the higher dividend yield at 0.37%, compared with 0.00% for BNO.
HELX is categorized as Health & Biotech Equities, while BNO is Oil & Gas. They also come from different issuers: Franklin Templeton and USCF. Their fees differ too: 0.50% for HELX and 1.00% for BNO.
HELX currently has the higher Sharpe Ratio (1.84 vs 1.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and BNO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer